Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:01 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2161–2184 of 3,416 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Routine Clear all

Conditions: Congenital Heart Disease
Interventions: Discarded blood samples, Discarded Urine Sample; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Breast Cancer
Interventions: Breast surgery; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 10
States / cities: Hartford, Connecticut • Ann Arbor, Michigan • Basking Ridge, New Jersey + 7 more

Conditions: Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events
Interventions: Alirocumab, Comparator: No PCSK9i Therapy (either mAb or siRNA); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 4,545 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Foot
Interventions: 2 Feet 4 Life; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 65 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Broken Arrow, Oklahoma • Owasso, Oklahoma

Conditions: Adolescent Substance Abuse, Attention Deficit Hyperactivity Disorder
Interventions: Medication integration protocol; Behavioral
Lead sponsor: The National Center on Addiction and Substance Abuse at Columbia University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Alpha1-Antitrypsin Deficiency
Interventions: No Intervention; Other
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 3
States / cities: Gainesville, Florida • Charleston, South Carolina • Nashville, Tennessee

Conditions: HIV/AIDS
Interventions: ADELANTE; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Miami, Florida • Houston, Texas

Conditions: Depression
Interventions: Mindfulness Based Cognitive Therapy; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ovarian Cancer
Interventions: Nudge; Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Diabetes
Interventions: Accu-Chek 360 software, Normal care; Other
Lead sponsor: Columbus Research Foundation; Other
Eligibility: 19 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Columbus, Georgia

Conditions: Pulmonary Disease
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 8 Years to 99 Years
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer
Interventions: Automated Breast Ultrasound (ABUS) as an adjunct to digital screening mammography; Device
Lead sponsor: U-Systems, Inc.; Industry
Eligibility: 25 Years and older · Female only
Enrollment: 15,679 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 11
States / cities: Indio, California • Monterey, California • Washington D.C., District of Columbia + 8 more

Conditions: Fetal Growth Restriction (FGR), Placental Insufficiency, Preeclampsia, Still Births, Pregnancy, Pregnancy Complications, Pregnancy Outcomes, Ultrasound
Interventions: ultrafast power Doppler imaging (uPDI) / quantitative ultrasound (QUS); Device
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Neck Pain, Low Back Pain
Interventions: Clinical Practice Guideline Implementation, Standard Care; Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,441 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Heart Failure
Interventions: Normal Salt Diet, Cardiac Diet; Other
Lead sponsor: Maya Guglin, MD; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Glioblastoma
Interventions: Bevacizumab, PD-L1 t-haNK, N-803, Tumor Treating Fields (TTFields, 200 kHz); Drug · Device
Lead sponsor: ImmunityBio, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 4
States / cities: El Segundo, California • Fullerton, California • Newport Beach, California + 1 more

Conditions: Hemorrhagic Shock, Acute Blood Loss Anemia, Traumatic Brain Injury
Interventions: Routine labs; Combination Product
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 199 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Major Depressive Disorder, Major Depressive Episode
Interventions: Universal Screening Arm; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: Not listed
Enrollment: 12,909 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Depression, Unipolar
Interventions: Hatha Yoga Practice Group, Attention Control Education Group; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 14 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sinus Node Dysfunction
Interventions: Treadmill/Bicycle exercise testing; Diagnostic Test
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Increase in Urobilinogen in Urine Prior to Delivery, Weight Loss After 37 Weeks Gestation Prior to Delivery
Interventions: Not listed
Lead sponsor: Oklahoma State University Center for Health Sciences; Other
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 2
States / cities: Tulsa, Oklahoma

Conditions: Cardiovascular Diseases, Coronary Disease, Coronary Artery Disease, Heart Diseases, Myocardial Ischemia
Interventions: cardiac catheterization, coronary artery bypass graft surgery, percutaneous coronary intervention, Lifestyle, Medication; Procedure · Behavioral · Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years and older
Enrollment: 5,179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 109
States / cities: Birmingham, Alabama • Yuma, Arizona • Beverly Hills, California + 82 more

Conditions: Proteinuria in Pregnancy
Interventions: Blood draw; Other
Lead sponsor: Marshall University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Huntington, West Virginia

Conditions: Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse, Pregnancy
Interventions: Epidiolex; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2033
U.S. locations: 1
States / cities: Morgantown, West Virginia

Search by objective public record fields.

Evaluation of Coagulation Testing in Patients Undergoing Cardiac Surgery

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Alirocumab and Ischemic Risk in Atherosclerotic Cardiovascular Disease (ASCVD)

Foot Self-care in Older Adults

Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care

A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV

Examining Cognitive Mechanisms of Clinical Improvement Following Mindfulness Based Therapy for Depressed Individuals

Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology

Remote Management of Diabetic Patients Via Data Transmission by Accu-Chek 360 Software

Evaluation and Treatment of Patients With Lung Disease Not Participating in Research

A Clinical Study to Evaluate Somo•v and Digital Mammography Together as a Breast Cancer Screening Method, Compared to Digital Mammography Alone, in Women With Dense Breasts.

Placental Imaging Techniques

Clinical Practice Guidelines for Neck and Low Back Pain in Outpatient Physical Therapy

The Salt Study for Heart Failure

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients

Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder

Treating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot Trial

Effectiveness of Closed Loop Stimulation (CLS) With His Bundle Lead Placement

Urobilinogen, Maternal Weight Loss and Impending Parturition at Term

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)

The Effect of Blood on the PC Ratio During Pregnancy

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy